You haven't answered my previous questions about how you know the FDA have serious concerns about the safety profile of iPPS, or why the reception was very, very lukewarm, but they decided to give it Fast Track designation - something reserved for new therapies showing safety, efficacy and superior treatment where there is a significant unmet need.
Maybe you have the courage to answer this one:
If there is a positive response from the TGA and/or the FDA will you apologize to Mozz for using him as your punching bag, or whatever it is you are up to?
New Player, page-52
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.0¢ | 23.0¢ | $74.10K | 315.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3245 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 3703 | 1 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |